InfuSystem Holdings (INFU) Total Non-Current Liabilities (2010 - 2019)
InfuSystem Holdings (INFU) reported Total Non-Current Liabilities of $52.1 million for Q2 2019, up 53.89% on a YoY basis from $33.9 million in Q2 2018, and up 9.7% quarter-over-quarter from $47.5 million in Q1 2019.
InfuSystem Holdings (INFU) Total Non-Current Liabilities (2010 - 2019) Analysis & Trends
InfuSystem Holdings has reported Total Non-Current Liabilities for 9 years, with the latest figure at $52.1 million in Q2 2019.
- For the quarter ending Q2 2019, Total Non-Current Liabilities rose 53.89% year-over-year to $52.1 million; the trailing twelve-month figure through Jun 2019 stood at $52.1 million (up 53.89% YoY), and the FY2018 full-year result was $43.6 million, up 15.04% from the prior year.
- Total Non-Current Liabilities for Q2 2019 stood at $52.1 million, up from $47.5 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $52.1 million in Q2 2019, with the low at $2.1 million in Q1 2017.
- Historically, Total Non-Current Liabilities has averaged $34.1 million across 5 years, with a median of $33.8 million in 2018.
- Annual changes were most pronounced in 2016 — Total Non-Current Liabilities decreased 1.9% — and 2018, when it soared 1471.9%.
- InfuSystem Holdings' Total Non-Current Liabilities stood at $29.8 million in 2015, then fell by 1.9% to $29.2 million in 2016, then grew by 29.82% to $37.9 million in 2017, then gained by 15.04% to $43.6 million in 2018, then grew by 19.43% to $52.1 million in 2019.
- The last three Total Non-Current Liabilities figures came in at $52.1 million (Q2 2019), $47.5 million (Q1 2019), and $43.6 million (Q4 2018), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 3.47 Bn |
| 10 | InfuSystem Holdings | 189.78 Mn | 187.68 Mn | 19.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 52.11 Mn |
| Mar 31, 2019 | 47.50 Mn |
| Dec 31, 2018 | 43.63 Mn |
| Sep 30, 2018 | 43.39 Mn |
| Jun 30, 2018 | 33.86 Mn |
| Mar 31, 2018 | 33.73 Mn |
| Dec 31, 2017 | 37.93 Mn |
| Sep 30, 2017 | 26.64 Mn |
| Jun 30, 2017 | 29.02 Mn |
| Mar 31, 2017 | 2.15 Mn |
| Dec 31, 2016 | 29.22 Mn |
| Dec 31, 2015 | 29.78 Mn |
| Sep 30, 2013 | 34.77 Mn |
| Jun 30, 2013 | 34.94 Mn |
| Mar 31, 2013 | 35.70 Mn |
| Dec 31, 2012 | 37.51 Mn |
| Mar 31, 2012 | 35.62 Mn |
| Dec 31, 2011 | 35.68 Mn |
| Sep 30, 2011 | 38.36 Mn |
| Jun 30, 2011 | 36.01 Mn |